COVID-19 female patients with a mild (1–2) outcome had 3-fold decreased IL-6 compared to female patients with a severe clinical outcome (3–5) and 2-fold lower compared to COVID-19 male patients with a mild outcome (Figure 2A). The gene discussed is IL6; the disease is COVID-19.